Abstract Two new 24-membered macrolides, SPA-6952A and B, were isolated from the fermentation broth of Streptomyces sp. SPA-6952. The structures of the new macrolides were determined by spectral analyses, including 2D NMR techniques. These compounds exhibited cytotoxic activity against human promyelocytic leukemia HL-60 cells.
In screening for biologically active compounds from microbial sources, two new 24-membered macrolides, SPA-6952A (1) and B (2) (Fig. 1) , were isolated from the fermentation broth of Streptomyces sp. SPA-6952. In this paper we report the fermentation, isolation, structure elucidation, and biological activity of 1 and 2.
The actinomycete strain SPA-6952 was isolated from a soil sample collected in Osaka Prefecture, Japan, and identified as a Streptomyces sp. A slant culture of the strain SPA-6952 was inoculated into a 500-ml Sakaguchi flask containing 75 ml of liquid medium composed of glucose 1.5%, soluble starch 1.5%, cottonseed flour 1.2%, yeast extract 0.05%, KCl 0.2%, MgSO 4 · 7H 2 O 0.007%, CaCO 3 0.2%, pH 7.2, and cultured for 4 days at 27°C with reciprocal shaking at 130 rpm. A volume of 6 ml of the seed culture was transferred into 2-liter Sakaguchi flasks containing 300 ml of the same medium, and cultured for 7 days at 27°C with reciprocal shaking at 115 rpm.
The fermentation broth (7.2 liters) was centrifuged at 9,000 g for 10 minutes at 20°C. The supernatant and mycelial cake were extracted with 7.2 liters of 1-butanol and 3 liters of acetone, respectively. Both extracts were concentrated under reduced pressure and combined to yield 8.5 g of brown oil. The oily residue was applied to a column of Toyopearl HW-40F (Tosoh) and eluted with methanol. The fractions containing 1 and 2 were separated into I (1.3 g) and II (4.2 g), respectively, after analysis by HPLC. The fraction I was subjected to preparative HPLC equipped with Wakopak Wakosil-II5C18HG-Prep columns (30ϫ100ϩ30ϫ250 mm). The elution was performed with a 1% aqueous formic acid -methanol gradient (30 : 70 to 0 : 100 in 40 minutes) at a flow rate of 20 ml/minute and detection of UV absorption at 225 nm. The fraction eluted at 24.0 minutes was further purified by preparative HPLC equipped with Wakopak Wakosil-II5C18RS columns (20ϫ50ϩ20ϫ250 mm) using a 1% aqueous formic acidmethanol gradient (45 : 55 to 40 : 60 in 60 minutes) at a flow rate of 7 ml/minute and detection of UV absorption at 225 nm. Compound 1 (5.9 mg) was eluted at 18.0 minutes and obtained as a colorless solid. Similarly, compound 2 was purified from the fraction II by using preparative HPLC twice, first using a gradient of 1% aqueous formic acid -methanol (30 : 70 to 0 : 100 in 45 minutes) at a flow rate of 30 ml/minute on a Wakosil-II5C18HG-Prep columns (50ϫ100ϩ50ϫ250 mm) and secondly a gradient New 24-Membered Macrolides SPA-6952A and B Produced by Streptomyces sp.
of 1% aqueous formic acid -methanol (40 : 60 to 0 : 100 in 72 minutes) at a flow rate of 7 ml/minute on a Wakosil-II5C18RS columns (20ϫ50ϩ20ϫ250 mm). Finally, compound 2 (4.0 mg) was eluted at 35.0 minutes and obtained as a colorless solid.
The physico-chemical properties of 1 and 2 are summarized in Table 1 . Both 1 and 2 are soluble in DMSO and MeOH, while they are insoluble in H 2 O and n-Hexane. Their UV and IR spectra had almost the same absorption maxima, and the UV spectrum (l max 257 nm) and IR absorption band (n max 1716 cm Ϫ1 ) suggested the existence of an a,b-unsaturated ester. The presence of a conjugated diene was also indicated by the IR spectrum (n max 1653 cm Ϫ1 ). The molecular formula of 1 was determined as C 49 H 83 NO 13 by HRFAB-MS. The 1 H and 13 C NMR (Tables  2 and 3 ) and DEPT spectral data of 1 indicated that 1 contained ten methyl groups, fifteen methylene groups, three methine groups, ten oxymethine groups and four quaternary carbons bearing oxygen, as well as a conjugated diene and an a,b-unsaturated ester. Detailed analysis of the COSY, HOHAHA and HMBC spectra of 1 revealed that 1 was a spiroketal 24-membered macrolide with an amino sugar and a conjugated diene fused to the dihydrofuran moiety (Fig. 2) . The linkage of the amino sugar to the C-8 position of the aglycone was established by HMBC correlations of H-8 with C-1Ј and of H-1Ј with C-8. These data were similar to those of dunaimycin D3S [1] . Compound 1 contained ten methyl groups, whereas dunaimycin D3S had eleven methyls. Comparisons of the NMR data between 1 and dunaimycin D3S indicated that 1 differed from dunaimycin D3S by the absence of a methyl substituent at C-28 in the spiroketal ring system. From these results along with unambiguous HMBC correlations of each of ten methyl groups in 1, compound 1 was 410 determined to be a new 28-demethylated analogue of dunaimycin D3S, as shown in Fig. 1 . The molecular formula of 2 was established as C 41 H 68 O 12 by HRFAB-MS. Comparisons of the molecular formula and the NMR data between 1 and 2 indicated that 2 was an aglycone of 1, and determined to be a new 28-demethylated aglycone of dunaimycin D3S as shown in Fig. 1 . Compounds 1 and 2 also bear close resemblance to ossamycin [2] and NK154183A and B [3] , which have been reported from Streptomyces spp.
Compounds 1 and 2 exhibited cytotoxic activity against human promyelocytic leukemia HL-60 cells with IC 50 values of 0.5 and 0.4 mg/ml, respectively. In antimicrobial assay, compounds 1 and 2 were active against Bacillus subtilis ATCC 6633 and Aspergillus niger JCM 10254 with the same MIC value of 50 mg/ml, but showed no inhibition against Candida utilis NBRC 10707 (MICϾ100 mg/ml). 
